Insulin aspart, recombinant Subcutaneous and Terbinafine Hydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Terbinafine Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: terbinafine
Brand name: Lamisil, Terbinex
Synonyms: Terbinafine, Terbinafine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Terbinafine Oral Granules
- Insulin aspart, recombinant Subcutaneous-Terbinafine Tablets
- Insulin aspart, recombinant Subcutaneous-Terbinafine Tablets and Hydroxypropyl-Chitosan Nail Lacquer
- Insulin aspart, recombinant Subcutaneous-Terbinex
- Insulin aspart, recombinant Subcutaneous-Terbutaline
- Insulin aspart, recombinant Subcutaneous-Terbutaline Injection
- Terbinafine Hydrochloride-Insulin degludec
- Terbinafine Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Terbinafine Hydrochloride-Insulin Degludec (U-100) Vials
- Terbinafine Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Terbinafine Hydrochloride-Insulin degludec and liraglutide
- Terbinafine Hydrochloride-Insulin degludec and liraglutide Subcutaneous